Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

 

Search in our Online Store

Drug Delivery
Filter     Order     Display # 
Date Item Title
27 Jan 2006 European Commission Approves Exubera® (Inhaled Human Insulin) for Treatment of Type 1 and Type 2 Diabetes
27 Jan 2006 Cipher provides cip-tramadol er update
26 Jan 2006 MedPharm Announces Evaluation Agreement for MedSpray; UK Pharmaceutical Development Expert Predicts Stream of Licensing Enquiries for its Innovative 'Patch in a Can'(TM) Delivery Technology
25 Jan 2006 Targeted genetics announces strategic restructuring to reduce expenses and advance lead inflammatory arthritis product candidate
25 Jan 2006 BiovaxID(TM) Yields 89% Survival in Patients with Aggressive Non-Hodgkins Mantle Cell Lymphoma at Median Follow-up of 3.8 Years
24 Jan 2006 Noven Provides Update on Vivelle-Dot(TM) Estrogen Patch
24 Jan 2006 Preliminary Phase IIb Study Shows Dyloject™ Relieves Postoperative Pain Faster
23 Jan 2006 Santarus Announces Publication of Peer-Reviewed Journal Articles on ZEGERID in Treating Upper GI Diseases and Disorders
10 Jan 2006 Elan and EntreMed Execute License Agreement for Proprietary NanoCrystal® Technology
09 Jan 2006 Alkermes and Lilly Announce Agreement for the Development and Commercialization of Inhaled Parathyro
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 Next > End >>
Results 401 - 410 of 410

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Thrombopoiesis-Stimulating Agents (TPO)

Order Now

Brief Report Series

CD40 and CD40L (CD154) Agonists & Antagonists

Order Now

Subscribe La Merie Biologics